Eritoran tetrasodiumProduct ingredient for Eritoran

Name: Eritoran tetrasodium
Drug Entry: Eritoran

Eritoran is a structural analogue of the lipid A portion of lipopolysaccharide (LPS). It is being developed by Eisai Research Institute of Boston for the treatment of severe sepsis.

See full entry for Eritoran
Accession Number: DBSALT001799
Structure: MOL SDF PDB SMILES InChI
Structure for Eritoran tetrasodium (DBSALT001799)
Synonyms: Eritoran sodium / Eritoran tetrasodium salt